Plus TherapeuticsCNSY
13F holders, Q3 2024 (September 30)11holders −1
1new positions
2sold out
$1.46avg. 13F price*
At the end of Q3 2024, 11 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($819K), Geode Capital Management, LLC ($79K) and Vanguard Group Inc. ($48K).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 2 | $32K |
All 13F filers, Q2 2024 → Q3 2024: 19,726 shares bought and 29,735 shares sold, net −10,009 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| AIGH Capital Management LLC | 0.38% | Reduce -1.4% | 560,905 | $819K |
| Geode Capital Management, LLC | 0.00% | Add +16.4% | 54,274 | $79K |
| Vanguard Group Inc. | 0.00% | No change | 32,541 | $48K |
| Ashton Thomas Private Wealth, LLC | 0.00% | Add +1484.4% | 12,913 | $19K |
| BlackRock, Inc. | 0.00% | — | 6,960 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -11.4% | 3,709 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $194 |
| JPMorgan Chase & Co. | 0.00% | No change | 100 | $146 |
| Bank of America Corp. | 0.00% | Add +2.1% | 48 | $70 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
| Group One Trading LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.